Search

everythinglearnresearchcommunity

for

Search:↓

Oral JAK inhibitors are effective and safe for treating alopecia areata but may need ongoing use to keep results.

Alopecia areata severity and treatment response are linked to specific cytokine levels.

The Italian guidelines offer advice for diagnosing and treating alopecia areata based on expert opinion and limited clinical trial evidence.

People with Major Depressive Disorder have a higher chance of getting Alopecia Areata, and vice versa; antidepressants may lower this risk.

Ruxolitinib can help regrow hair in severe alopecia areata.

People with alopecia areata often have lower vitamin D levels and more inflammation, suggesting vitamin D might be involved in the condition.

Black and Hispanic women are more likely to have alopecia areata than white women.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

Trichoscopy helps tell apart alopecia areata and trichotillomania in Asians by looking at specific hair and scalp features.

Diphencyprone can help some children with alopecia areata regrow hair, but it often causes side effects.

Narrowband UVB phototherapy alone is not very effective for treating alopecia areata.

Bimatoprost helped eyelash growth in nearly half of the patients with a type of eyelash hair loss.

Hair loss in mice starts with immune cells damaging hair roots before it becomes visible.

Diphencyprone (DPC) is an effective and safe long-term treatment for alopecia areata, especially with maintenance therapy.

Turner's syndrome may be linked to autoimmune diseases like psoriasis and alopecia areata, needing comprehensive care.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

A substance called VIP might protect hair follicles from being attacked by the immune system, and problems with VIP signaling could lead to hair loss in alopecia areata.

Bimatoprost was found to be safer and more effective than mometasone furoate for treating scalp hair loss.

No treatments fully cure or prevent alopecia areata; some help but have side effects or need more research.

Intralesional steroids can help regrow hair in some alopecia areata patients but have side effects.

Certain HLA class II alleles increase or decrease the risk of alopecia areata.

DPCP is effective for treating severe alopecia areata, but relapse is common.

3% topical minoxidil effectively treats extensive alopecia areata.

Using minoxidil and anthralin together can improve hair regrowth in severe alopecia areata patients who didn't respond to individual treatments.

Children with alopecia areata should only have thyroid screening if they have Down syndrome, a history of atopy, family history of thyroid disease, or signs of thyroid problems.

Intralesional triamcinolone acetonide is effective for treating patchy hair loss, and dermoscopy helps detect treatment response and side effects early.

Dilated follicular infundibula and increased catagen/telogen follicles are key indicators for diagnosing alopecia areata.

Melanocytes might be targeted by the immune system in people with alopecia areata, but more research is needed.

A woman's hair loss during treatment with specific hepatitis C drugs grew back after stopping the medication.

Oxidative stress may play a role in causing alopecia areata.